[The impact of COVID-19 in patients with severe aortic stenosis: Artificial intelligence research]

Virginia Pascual-Tejerina1, Pedro Beneyto2, Tomás Cantón1

  • 1Servicio de Cardiología, Hospital Virgen de la Salud, Toledo, España.

Cirugia Espanola
|August 16, 2021
PubMed

Insights

The COVID-19 pandemic increased mortality for severe aortic stenosis patients. Both COVID-19 positive and negative patients experienced higher death rates during the pandemic compared to pre-COVID times.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Context:

  • Severe aortic stenosis carries a high mortality risk without intervention.
  • The COVID-19 pandemic significantly disrupted healthcare access and patient flow.
  • Understanding the pandemic's impact on cardiovascular disease outcomes is crucial.

Purpose:

  • To assess the effect of the COVID-19 pandemic's first wave on mortality in severe aortic stenosis patients.
  • To compare mortality rates during the pandemic with the same period in the previous year.
  • To analyze mortality differences between COVID-19 positive and negative patients with severe aortic stenosis.

Summary:

  • A Spanish region observed a 13.82% decrease in hospital admissions during the pandemic's first wave.
  • Among 1,112 patients with severe aortic stenosis, 5.48% tested positive for COVID-19.
  • Mortality rates were significantly higher in the pandemic period for both COVID-19 negative (4.37% vs. 2.57%) and positive (11.47%) patients compared to pre-COVID eras.

Impact:

  • The study highlights an excess mortality in severe aortic stenosis patients during the pandemic, irrespective of COVID-19 status.
  • Cardiac surgeries showed a decreasing trend, with a significant reduction in COVID-19 positive patients.
  • Findings underscore the pandemic's adverse effect on outcomes for vulnerable cardiovascular patient populations.
Abstract

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
85
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
84
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
55